Indian pharma stocks tumble amid US tariff concerns
With a large portion of pharma revenues coming from US exports, the risk of increased tariffs has led to margin worries and market pullback. Indian pharmaceutical industry is particularly vulnerable […]
India’s Lupin to Spin Off LupinLife Consumer Healthcare
July 1 – Indian drugmaker Lupin said on Tuesday it will spin off its consumer healthcare business, LupinLife Consumer Healthcare into a separate unit, effective July 1.